Sydney Cell and Gene Therapy

Sydney Cell and Gene Therapy (SCGT) is a premier Australian contract development and manufacturing organization (CDMO) focused on the advancement of cell and gene-based therapeutics. Established as a joint venture between the Sydney Children's Hospitals Network, Westmead Hospital, and the Children's Medical Research Institute, SCGT provides comprehensive services ranging from process development to TGA-licensed GMP manufacturing. The organization specializes in the production of viral vectors, such as lentivirus and AAV, as well as the processing of gene-modified cellular products like CAR-T cells. By bridging the gap between laboratory research and clinical application, SCGT supports a diverse range of clinical trials for both academic and commercial partners globally.